Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Browse by cancer
Tags
Search
Connections
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
Checkpoint side effects
Tumour board
Compare
Counts by category
Rankings
Timeline
Year by year
Query builder
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Institutions
Universities
Trial leadership
People
Heroes and heroines
Companies
Startups
Requests for startups
Investors
Company scorecards
Trial sponsors
Manufacturing map
Countries
United States deep dive
India deep dive
China deep dive
Germany deep dive
Israel deep dive
United Kingdom deep dive
Cases by country
Funding flows

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Recovery and rejuvenation
Complementary and supportive approaches
Hair loss and regrowth
What comes back after treatment
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Coverage of the field
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Answer quality
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
The software of oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Cancers
Ependymoma
Data

Cancers·Ependymoma

DataEpendymoma

Back to the Ependymoma hub →39 connected records

Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.

Overview Types and stages Symptoms and diagnosis Treatment Trials and papers Biology and targets Countries and centres Decisions and support Pipeline and open problems Data

Data

Related pages

39

Direct links plus the targets, companies, and technologies of this cancer's products.

Similar pages

Cancer
Craniopharyngioma
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, St. Jude Children's Research Hospital and the tags paediatric, cns.
Cancer
Diffuse midline glioma, H3 K27-altered (including DIPG)
Shares A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer, Brain tumor pathology, CNS oncology, Journal of neuro-oncology and the tags paediatric, cns.
Trial
TADPOLE (CDRB436G2201)
Shares Paediatric low-grade glioma, Vincristine, Carboplatin and the tags paediatric, cns.
Trial
FIREFLY-1
Shares Paediatric low-grade glioma and the tags paediatric, cns.
Trial
ACTION
Shares Rare and paediatric cancers without markets and the tags paediatric, cns.
Cancer
WNT-activated medulloblastoma
Shares SIOP Europe (European Society for Paediatric Oncology), St. Jude Children's Research Hospital, DNA methylation profiling, Medulloblastoma and the tags paediatric, cns.
Cancer
Central nervous system germ cell tumours (germinoma and non-germinomatous)
Shares SIOP Europe (European Society for Paediatric Oncology), Atypical teratoid/rhabdoid tumour (ATRT), Brain and spinal cord tumours (all types), Medulloblastoma and the tags paediatric, cns.
Cancer
Group 3 and group 4 medulloblastoma (non-WNT/non-SHH)
Shares SIOP Europe (European Society for Paediatric Oncology), St. Jude Children's Research Hospital, DNA methylation profiling, Medulloblastoma and the tags paediatric, cns.

technologies

Allogeneic stem cell transplantation Autologous stem cell transplant (high-dose therapy)CAR-T cell therapy Cytotoxic chemotherapy DNA methylation profiling IMRT / IGRT (modern external beam)MRI Platinum agents Proton therapy Survivorship care and late-effects surveillance Topoisomerase-I inhibitors (and ADC payloads)

targets

CDK4/6 KMT2A (MLL) rearrangement

drugs

ApprovedCytotoxic chemotherapy (platinum)

ApprovedAlkylating agent (oxazaphosphorine prodrug)

Cyclophosphamide · Cytoxan / Endoxan

ApprovedTopoisomerase II inhibitor (podophyllotoxin derivative)

Etoposide · VePesid / Etopophos / Toposar

ApprovedVinca alkaloid (microtubule inhibitor)

Vincristine · Oncovin / Marqibo

companies

Bristol Myers Squibb Children's Oncology Group (COG)Eli Lilly (incl. Loxo)

institutions

German Cancer Research Center (DKFZ)SIOP Europe (European Society for Paediatric Oncology)St. Jude Children's Research Hospital

pathways

Epigenetic reprogramming Hippo-YAP/TAZ Inflammation & NF-κB

terms

Ependymoma molecular groups (PF-A, PF-B, ZFTA, YAP1, MYCN)Epigenetic progenitor theory: cancer without a first mutation Late effects and survivorship toxicity

trials

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer ACNS0121 NCI-COG Pediatric MATCH (APEC1621)

bottlenecks

Rare and paediatric cancers without markets Survivorship and late effects are neglected

key papers

ACNS0121: conformal radiotherapy for paediatric ependymoma, chemotherapy for incompletely resected tumours and observation after complete resection Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

journals

Brain tumor pathology CNS oncology Journal of neuro-oncology

Machine-readable versions

The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.

JSON with neighbours Markdown context RDF Turtle Sections with routes and counts API root

ProvenanceLast edited 2026-09-25 · Jude Gomila · One home for cooperative groups · diff · file

Wikipedia

Sources & links

NCI PDQ: childhood ependymoma
Pajtler 2015: molecular classification of ependymal tumours (Cancer Cell)
ACNS0121: conformal radiotherapy in childhood ependymoma (JCO 2019)

Data

JSON ·

Follow this page

Wrong or missing?

Propose a change with a source. Organisations can update their own records. Every suggestion is reviewed, safety-checked and validated before it goes live; nothing is edited directly.

Suggest an editDiscuss start a thread

Out of date?
How review works

Not yet reviewedNeeds expert (clinical) and patient advocate review. Review this page or see the review queue and roster.

Model panel commentary is coming to this page: machine commentary, not clinical review.

Machine-readable versions of Ependymoma

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/cancers/ependymoma/)
Section plan: the ten sections of this record with routes, anchors and counts
All cancers as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id ependymoma.

WebMCP tools registered on this page: onco_search, onco_get_entity.